What other genetic disorders could explain prematurity, low birth weight, persistent failure to thrive, and continued low weight into adulthood after Prader‑Willi syndrome has been excluded, and what diagnostic work‑up should be performed?

Differential Diagnosis After Excluding Prader-Willi Syndrome

When Prader-Willi syndrome has been excluded in a patient with prematurity, low birth weight, persistent failure to thrive, and continued low weight into adulthood, you should systematically evaluate for other genetic syndromes, particularly those with overlapping features of hypotonia, feeding difficulties, and growth failure, followed by targeted genetic testing based on specific clinical phenotypes.

Key Distinguishing Clinical Features to Assess

After excluding PWS, focus your evaluation on identifying specific phenotypic patterns that guide genetic testing:

Primary Assessment Points

Facial dysmorphology patterns:

• Williams syndrome: elfin facies, periorbital fullness, stellate iris pattern
• Dubowitz syndrome: microcephaly, eczema, distinctive facial features
• Fetal alcohol syndrome (FAS): smooth philtrum, thin vermillion border, small palpebral fissures (though FAS has all three features like PWS, the overall constellation differs) 1

Neurological features:

• Assess for structural brain abnormalities via MRI if not already done 2
• Document specific patterns of developmental delay (global vs. domain-specific)
• Evaluate for hypotonia persistence and quality (central vs. peripheral)

Growth pattern specificity:

• Distinguish prenatal vs. postnatal growth failure
• Assess for proportionate vs. disproportionate short stature
• Rule out skeletal dysplasias if disproportionate 1

Structured Diagnostic Work-Up

First-Tier Genetic Testing

1. Chromosomal Microarray Analysis (CMA)

• Detects pathogenic copy number variants in 10-31% of cases with neurodevelopmental disorders 3
• Particularly important given the clinical presentation includes multiple congenital anomalies

2. Comprehensive Metabolic Screening

• Consider short-chain acyl-CoA dehydrogenase (SCAD) deficiency, which can present with neonatal hypotonia, growth failure, and developmental delays similar to early PWS 4
• Obtain plasma acylcarnitine profile and urine organic acids
• SCAD gene variant (625 G-to-A and 511 C-to-T changes) impairs C4-C6 fatty acid metabolism

3. Targeted Gene Panel or Exome Sequencing

• Exome sequencing is now recommended as first- or second-tier testing for patients with intellectual disability/developmental delay or congenital anomalies 3
• Diagnostic yield of 20-42% in neurodevelopmental disorders 3
• Consider this early rather than sequential single-gene testing

Specific Genetic Syndromes to Consider

Syndromes with similar neonatal presentation:

• 22q11.2 deletion syndrome: If congenital heart disease present (particularly conotruncal anomalies), obtain FISH testing for 22q11.2 microdeletion 2

• Silver-Russell syndrome: Asymmetric growth restriction, relative macrocephaly, feeding difficulties

• Noonan syndrome: Short stature, cardiac defects, distinctive facial features, feeding difficulties in infancy

• Congenital disorders of glycosylation: Hypotonia, failure to thrive, developmental delay

Second-Tier Investigations

If initial genetic testing is negative:

• Whole genome sequencing: Higher diagnostic yield than exome sequencing for structural variants
• Methylation studies: For other imprinting disorders beyond PWS
• Mitochondrial DNA analysis: If lactic acidosis or multi-system involvement

Environmental and Teratogenic Causes

Fetal Alcohol Syndrome evaluation 1:

• Requires all three cardinal features:
  • Growth deficiency (height/weight ≤10th percentile)
  • Characteristic facial dysmorphology (smooth philtrum, thin vermillion border, small palpebral fissures)
  • CNS abnormalities (structural, neurological, or functional deficits)
• Obtain detailed maternal history regarding prenatal alcohol exposure
• Neuropsychological testing across multiple functional domains

Critical Pitfalls to Avoid

1. Assuming birth complications explain everything: Birth asphyxia accounts for less than 10% of cases with persistent neurological impairment; genetic causes are far more common than historically recognized 3

2. Sequential single-gene testing: This approach is outdated and delays diagnosis. Exome sequencing should be considered early given its 20-42% diagnostic yield 3

3. Missing syndromic features: Perform systematic evaluation for:

• Cardiac anomalies (echocardiography)
• Renal anomalies (ultrasound)
• Ophthalmologic abnormalities
• Hearing assessment
• Endocrine dysfunction (thyroid, growth hormone, cortisol)

4. Inadequate nutritional assessment: Growth failure may have both genetic and environmental components requiring simultaneous intervention

Genetic Consultation Indications

Refer to genetics immediately if 2:

• Intellectual disability present
• Multiple congenital anomalies
• Facial dysmorphism
• Failure to thrive not explained by cardiac or other organ dysfunction
• Microcephaly
• Persistent hypotonia

Practical Testing Algorithm

1. Confirm PWS exclusion with methylation-specific testing (MLPA or methylation-specific PCR) 5
2. Obtain chromosomal microarray as first genetic test
3. Perform exome sequencing if CMA negative and clinical suspicion remains high
4. Complete metabolic screening including acylcarnitine profile
5. Evaluate for FAS if maternal alcohol exposure possible
6. Consider whole genome sequencing if exome negative but phenotype strongly suggests genetic etiology

The key is recognizing that genetic causes are far more common than previously appreciated in children with persistent growth failure and developmental delays, and early comprehensive genetic testing improves diagnostic yield and guides management 3.